GP531 is primarily utilized in the field of medical research and therapeutics, particularly in the development of treatments for cardiovascular diseases. It functions as a novel agent that targets specific pathways involved in heart function and blood pressure regulation. Researchers are exploring its potential to improve cardiac output and manage hypertension, offering a promising approach for patients with chronic heart conditions. Additionally, GP531 is being studied for its role in reducing oxidative stress and inflammation, which are key factors in the progression of cardiovascular disorders. Its application extends to preclinical and clinical trials, where it is evaluated for safety, efficacy, and optimal dosing strategies.